Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

5(71.4%)

N/A

1(14.3%)

Phase 1

1(14.3%)

7Total

Phase 2(5)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06385561Phase 2Completed

The Influence of Tramadol on Opioid-induced Bowel Dysfunction

Role: lead

NCT05690321Phase 2Completed

Opium Tincture Against Chronic Diarrhea - Patients

Role: lead

NCT06334198Phase 2Recruiting

The Effect of Naldemedine on Opioid-induced Bowel Dysfunction

Role: lead

NCT04966559Phase 2Active Not Recruiting

Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis

Role: lead

NCT04743570Phase 2Completed

Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis

Role: lead

NCT05702190Not ApplicableCompleted

Opium Tincture Against Chronic Diarrhea - Healthy

Role: lead

NCT03701672Unknown

Identification of Predictive Markers of the Effects of Opioid Therapy in Patients With Chronic Pain.

Role: lead

NCT01818570Phase 1Completed

A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus

Role: lead

All 8 trials loaded